sulfamethoxazole hydroxylamine has been researched along with trimellitic anhydride in 1 studies
| Studies (sulfamethoxazole hydroxylamine) | Trials (sulfamethoxazole hydroxylamine) | Recent Studies (post-2010) (sulfamethoxazole hydroxylamine) | Studies (trimellitic anhydride) | Trials (trimellitic anhydride) | Recent Studies (post-2010) (trimellitic anhydride) |
|---|---|---|---|---|---|
| 45 | 6 | 7 | 235 | 0 | 31 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dearman, RJ; Hopkins, JE; Humphreys, N; Kimber, I; Naisbitt, DJ; Park, BK | 1 |
1 other study(ies) available for sulfamethoxazole hydroxylamine and trimellitic anhydride
| Article | Year |
|---|---|
Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.
Topics: Animals; Anti-Infective Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Dinitrochlorobenzene; Drug Hypersensitivity; Enzyme-Linked Immunosorbent Assay; Female; Interleukin-5; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Nitroso Compounds; Phthalic Anhydrides; Sulfamethoxazole; Th1 Cells; Th2 Cells | 2005 |